Publication & Citation Trends
Publications
0 total
First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC) OA
Cited by 17
Semantic Scholar
PI3Kγ stimulates a high molecular weight form of myosin light chain kinase to promote myeloid cell adhesion and tumor inflammation OA
Cited by 18
Semantic Scholar
TAMI-41. PI3K-GAMMA INHIBITION SUPPRESSES ACCUMULATION OF GLIOBLASTOMA-ASSOCIATED MICROGLIA TO RECAPITULATE THE MICROENVIRONMENT OF EXCEPTIONAL RESPONDERS OA
Cited by 1
Semantic Scholar
PI3Kγ inhibition suppresses microglia/TAM accumulation in glioblastoma microenvironment to promote exceptional temozolomide response OA
Cited by 69
Semantic Scholar
Abstract 113: c-Kit-dependent tissue resident macrophage progenitors drive cancer progression OA
Cited by 0
Semantic Scholar
Abstract 5006: Kit-dependent tissue resident macrophage progenitors drive cancer progression OA
Cited by 0
Semantic Scholar
Integrin CD11b activation drives anti-tumor innate immunity OA
Cited by 237
Semantic Scholar
PI3Kγ Activates Integrin α4 and Promotes Immune Suppressive Myeloid Cell Polarization during Tumor Progression OA
Cited by 57
Semantic Scholar
Research Topics
Pancreatic and Hepatic Oncology Research
(26)
Immune cells in cancer
(26)
Phagocytosis and Immune Regulation
(16)
Pancreatitis Pathology and Treatment
(9)
Cell Adhesion Molecules Research
(8)
Affiliations
Pfizer (United States)
Washington University in St. Louis
University of California, San Diego
Moores Cancer Center